Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03497637
Other study ID # HRC045277
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 23, 2020
Est. completion date November 1, 2026

Study information

Verified date September 2023
Source Helios Health Institute GmbH
Contact Holger Thiele, MD
Phone +49 341 865 1428
Email holger.thiele@medizin.uni-leipzig.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, randomized, controlled, multicenter, open-label study designed to assess whether vFFR is non-inferior to FFR in assessment of intermediate coronary stenosis in terms of the occurrence of MACE during 12 months after randomization.


Description:

Coronary angiography is insensitive to assess the physiologic significance of a coronary stenosis. Therefore, clinical guidelines support the use of pressure-derived fractional flow reserve (FFR) to assess the hemodynamic significance of coronary stenosis. Nevertheless, the penetration of FFR in clinical routine continues to be limited by its requirement for pharmacological vasodilation, prolonged procedure time and adverse systemic effects from adenosine. Vessel-FFR (vFFR) is a novel method for evaluating the functional significance of coronary stenosis by calculation of the pressure drop in the vessel based on computation of two angiographic projections. The vFFR values at each point along the vessel are color-coded and superimposed on the 3D epicardial model and cut-off values of ≤0.80 identical to standard invasive FFR apply. These developments may translate towards more physiology guided intervention bearing the potential to improve clinical outcomes in patients with stable CAD. The ability to derive FFR values from routinely performed coronary angiograms, without the practical drawbacks that limit invasive techniques, could have an important impact on daily clinical practice. To date no randomized outcome-based clinical trial has compared an image-based FFR methodology with standard invasive FFR in terms of subsequent clinical outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 1926
Est. completion date November 1, 2026
Est. primary completion date May 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age >18 years - Willing to participate and able to understand, read and sign the informed consent document before the planned procedure - Eligible for coronary angiography and/or PCI - Coronary artery disease in one or more native major epicardial vessels or their branches by coronary angiogram with visually assessed de novo coronary stenosis in which the physiological severity of the lesion is in question (typically 40-80% diameter stenosis). - Stable angina or acute coronary syndrome (non-culprit vessels only and outside of primary intervention during acute STEMI or NSTE-ACS) - Participation in another interventional study Exclusion Criteria: - Previous CABG with patent grafts to the interrogated vessel - Tandem stenoses separated by more than 10 mm that require separate pressure guide wire interrogation or PCI (not to be interrogated or treated as a single stenosis) - Total coronary occlusions - Hemodynamic instability (Killip class III-IV) - Heavily calcified or tortuous vessels - Terminal disease with life expectancy of less than 12 months - STEMI within 48 hours of procedure - Severe valvular heart disease - ACS patients with difficulty in assessing which the culprit lesion is - Significant contraindication to adenosine administration (e.g. Asthma bronchiale) - Pregnancy

Study Design


Intervention

Diagnostic Test:
measurement of FFR
use of pressure-derived FFR to assess the hemodynamic significance of coronary stenoses
measurement of Pd/Pa
use of resting distal coronary pressure to aortic pressure ratio (Pd/Pa) to assess the hemodynamic significance of coronary stenoses

Locations

Country Name City State
Germany Heart Center Dresden - University Clinic Dresden
Germany University Clinic Erlangen Erlangen
Germany Universitätsklinikum Essen Essen
Germany University Clinic Giessen and Marburg Gießen
Germany Herzzentrum Leipzig Leipzig
Germany University Clinic Leipzig Leipzig
Germany Klinikum der Stadt Ludwigshafen Ludwigshafen
Germany Lukaskrankenhaus Neuss Neuss

Sponsors (2)

Lead Sponsor Collaborator
Helios Health Institute GmbH Heart Center Leipzig - University Hospital

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Major Adverse Cardiac Event (MACE) rate composite of cardiac death, non-fatal myocardial infarction or unplanned revascularization 1 year
Secondary MACE during long-term follow-up 2 and 5 years
Secondary Each component of the primary endpoint assessed by structured telephone interview and verification by hospital reports 1, 2 and 5 years
Secondary Repeat revascularization (PCI or CABG) assessed by structured telephone interview and verification by hospital reports in case of event 1, 2 and 5 years
Secondary All-cause mortality 1, 2 and 5 years
Secondary Cross-over rate from the one strategy to the other at intervention
Secondary Number of analyzable lesions in both treatment arms at intervention
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A